Zoya Poltorak

Title: Zoya Poltorak: Innovator in Cardiovascular Treatments

Introduction

Zoya Poltorak is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of cardiovascular medicine through her innovative research and patented inventions. With a total of 3 patents, her work focuses on angiogenic factors and their applications in treating cardiovascular diseases.

Latest Patents

Poltorak's latest patents include groundbreaking inventions related to vascular endothelial growth factor (VEGF) protein products. One of her notable inventions is a novel VEGF protein product and nucleic acid encoding it, which comprises exons 1-6 and 8 of the VEGF gene. This invention aims to treat cardiovascular diseases by enhancing the anatomy, conduit function, and permeability of the cardiovascular system. The novel VEGF protein has unique properties compared to previously characterized VEGF species, particularly in its cellular distribution and susceptibility to oxidative damage. Additionally, her patents provide methods for enhancing endothelialization of diseased vessels and improving drug permeation.

Career Highlights

Zoya Poltorak is associated with the Technion Research & Development Foundation Limited, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize treatments for cardiovascular diseases, making her a key figure in the field.

Collaborations

Poltorak collaborates with esteemed colleagues such as Gera Neufeld and Eli Keshet, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Zoya Poltorak's contributions to cardiovascular medicine through her patented inventions highlight her role as a leading innovator in the field. Her work not only advances scientific understanding but also holds promise for improving patient outcomes in cardiovascular health.